Feasibility of Oxaliplatin, Leucovorin, and 5-Fluorouracil (FOLFOX-4) Chemotherapy in Heavily Pretreated Patients with Recurrent Epithelial Ovarian Cancer
Hee Jun Lee, Hee Seung Kim, Noh Hyun Park, Hyun Hoon Chung, Jae Weon Kim, Yong Sang Song
Cancer Res Treat. 2013;45(1):40-47.   Published online 2013 Mar 31     DOI: https://doi.org/10.4143/crt.2013.45.1.40
Citations to this article as recorded by Crossref logo
Antitumour effects of a solid lipid nanoparticle loaded with gemcitabine and oxaliplatin on the viability, apoptosis, autophagy, and Hsp90 of ovarian cancer cells
Ashwaq A. Al-Mutairi, Mayson H. Alkhatib
Journal of Microencapsulation.2022; 39(5): 467.     CrossRef
In Vitro Employment of Recombinant Taenia solium Calreticulin as a Novel Strategy Against Breast and Ovarian Cancer Stem-like Cells
Alejandro Schcolnik-Cabrera, Mandy Juárez, Bernardo Oldak, Mayra Cruz-Rivera, Ana Flisser, Alfonso Dueñas-González, Vinnitsa Buzoianu-Anguiano, Sandra Orozco-Suarez, Fela Mendlovic
Archives of Medical Research.2020; 51(1): 65.     CrossRef
Mucinous Cancer of the Ovary: Overview and Current Status
Abdulaziz Babaier, Prafull Ghatage
Diagnostics.2020; 10(1): 52.     CrossRef
Oxaliplatin plus leucovorin and 5-fluorouracil (FOLFOX-4) as a salvage chemotherapy in heavily-pretreated platinum-resistant ovarian cancer
Vincenza Conteduca, Giorgia Gurioli, Lorena Rossi, Emanuela Scarpi, Cristian Lolli, Giuseppe Schepisi, Alberto Farolfi, Delia De Lisi, Valentina Gallà, Salvatore Luca Burgio, Cecilia Menna, Andrea Amadori, Lorena Losi, Dino Amadori, Maria Paola Costi, Ugo
BMC Cancer.2018;[Epub]     CrossRef
Malignant transformation of ovarian mature cystic teratoma into squamous cell carcinoma: a Taiwanese Gynecologic Oncology Group (TGOG) study
An-Jen Chiang, Min-Yu Chen, Chia-Sui Weng, Hao Lin, Chien-Hsing Lu, Peng-Hui Wang, Yu-Fang Huang, Ying-Cheng Chiang, Mu-Hsien Yu, Chih-Long Chang
Journal of Gynecologic Oncology.2017;[Epub]     CrossRef
Mucinous ovarian cancer: A therapeutic review
Wen Xu, Jack Rush, Kirsty Rickett, Jermaine I.G. Coward
Critical Reviews in Oncology/Hematology.2016; 102: 26.     CrossRef
Gemcitabine–oxaliplatin (GEMOX) for epithelial ovarian cancer patients resistant to platinum-based chemotherapy
Mohamed Elshebeiny, Walid Almorsy
Journal of the Egyptian National Cancer Institute.2016; 28(3): 183.     CrossRef
The American Society of Peritoneal Surface Malignancies Multi-Institution evaluation of 1,051 advanced ovarian cancer patients undergoing cytoreductive surgery and HIPEC: An introduction of the peritoneal surface disease severity score
Richard Sleightholm, Jason M. Foster, Lynette Smith, Wim Ceelen, Marcello Deraco, Yusuf Yildirim, Edward Levine, Cristobal Muñoz-Casares, Olivier Glehen, Asish Patel, Jesus Esquivel
Journal of Surgical Oncology.2016; 114(7): 779.     CrossRef
Ginseng Purified Dry Extract, BST204, Improved Cancer Chemotherapy-Related Fatigue and Toxicity in Mice
Hyun-Jung Park, Hyun Soo Shim, Jeom Yong Kim, Joo Young Kim, Sun Kyu Park, Insop Shim
Evidence-Based Complementary and Alternative Medicine.2015; 2015: 1.     CrossRef
A Series of Malignant Ovarian Cancers Arising From Within a Mature Cystic Teratoma
Jonathan D. Black, Dana M. Roque, Monica C. Pasternak, Natalia Buza, Thomas J. Rutherford, Peter E. Schwartz, Shirley McCarthy, Elena Ratner
International Journal of Gynecological Cancer.2015; 25(5): 792.     CrossRef
The efficacy and safety of Oxaliplatin-Vinorelbine as a second-line chemotherapy combination in patients with platinum-resistant pretreated epithelial ovarian cancer: A retrospective study
Fidia Mumtahana, Xinli Tiang, Teng Zhang, Baoxia Cui
International Journal of Cancer Therapy and Oncology.2014; 2(4): 020413.     CrossRef
Gastrointestinal Adverse Effects in Advanced Colorectal Carcinoma Patients Treated with Different Schedules of FOLFOX
Nusrat Bano, Rahila Najam, Faaiza Qazi, Ahmed Mateen
Asian Pacific Journal of Cancer Prevention.2014; 15(19): 8089.     CrossRef